SEARCH:   Advanced

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Capone, M. Articles by van Meerwijk, J. P. M. Search for Related Content PubMed PubMed Citation Articles by Capone, M. Articles by van Meerwijk, J. P. M. Related Collections Immunobiology Social Bookmarking                   What's this?  Previous Article  |  Table of Contents  |  Next Article  Blood, 1 March 2001, Vol. 97, No. 5, pp. 1336-1342 IMMUNOBIOLOGY Dissociation of thymic positive and negative selection in transgenic mice expressing major histocompatibility complex class I molecules exclusively on thymic cortical epithelial cells Myriam Capone, Paola Romagnoli, Friedrich Beermann, H. Robson MacDonald, and Joost P. M. van Meerwijk From the Ludwig Institute for Cancer Research, Lausanne Branch, University of Lausanne, Epalinges, Switzerland; the Institut National de la Santé et de la Recherche Médicale (INSERM), Toulouse, France; the Swiss Institute for Experimental Cancer Research, Epalinges, Switzerland; and the Faculty of Life Sciences (UFR-SVT), University Toulouse III, Toulouse, France.     Abstract Top Abstract Introduction Materials and methods Results Discussion References Thymic positive and negative selection of developing T lymphocytes confronts us with a paradox: How can a T-cell antigen receptor (TCR)-major histocompatibility complex (MHC)/peptide interaction in the former process lead to transduction of signals allowing for cell survival and in the latter induce programmed cell death or a hyporesponsive state known as anergy? One of the hypotheses put forward states that the outcome of a TCR-MHC/peptide interaction depends on the cell type presenting the selecting ligand to the developing thymocyte. Here we describe the development and lack of self-tolerance of CD8+ T lymphocytes in transgenic mice expressing MHC class I molecules in the thymus exclusively on cortical epithelial cells. Despite the absence of MHC class I expression on professional antigen-presenting cells, normal numbers of CD8+ cells were observed in the periphery. Upon specific activation, transgenic CD8+ T cells efficiently lysed syngeneic MHC class I+ targets in vitro and in vivo, indicating that thymic cortical epithelium (in contrast to medullary epithelium and antigen-presenting cells of hematopoietic origin) is incapable of tolerance induction. Thus, compartmentalization of the antigen-presenting cells involved in thymic positive selection and tolerance induction can (at least in part) explain the positive/negative selection paradox. (Blood. 2001;97:1336-1342) © 2001 by The American Society of Hematology.     Introduction Top Abstract Introduction Materials and methods Results Discussion References Because of the random nature of T-cell receptor alpha (TCR) and TCR gene rearrangements, the developing T-cell repertoire needs to undergo positive and negative selection processes. Thymic positive selection is thought to enrich for T cells expressing a clonotypic TCR capable of interaction with self-major histocompatibility complex (MHC) heterodimers, although alternative views exist. Thymic negative selection eliminates or inactivates self-reactive T lymphocytes through induction of apoptosis and anergy. Although negative selection probably rids the developing T-cell repertoire of the majority of self-reactivity, peripheral tolerance mechanisms survey remaining self-specific T-cell clones. The resulting peripherally circulating T-cell repertoire is capable of recognition of foreign, but not self-peptides presented by self-MHC molecules.1-5 Because thymic positive and negative selection both involve TCR-MHC/peptide interactions, an important issue is what determines the outcome of such an interaction. Initially, studies have focused on the thymic stromal cell types involved in thymic selection. It has been known that MHC/peptide complexes expressed on cortical epithelium are capable of positive selection of conventional TCR+ thymocytes, whereas medullary epithelium as well as antigen-presenting cells (APCs) of hematopoietic origin cannot,6-8 although quantitatively minor exceptions to this rule have been reported.9,10 On the other hand, negative selection is known to be mediated primarily by APCs of hematopoietic origin (reviewed in Anderson et al1 and Laufer et al11). Given the fact that thymic epithelium can induce positive selection while APCs cannot, it was conceivable that differences in the repertoire of presented peptides play a role in the outcome of a TCR-MHC/peptide interaction. Although peptide elution studies from epithelial cells and APCs have thus far failed to confirm this hypothesis,12 several lines of evidence indicate that thymic epithelial cells have specialized antigen presentation properties and may present different peptides from those presented by professional APC.13-18 Therefore, an interaction with MHC/peptide ligands expressed by thymic epithelial cells may allow for positive selection, and these cells would subsequently not be negatively selected because the same ligand is not expressed on cells capable of negative selection. However, in mice expressing MHC class II molecules loaded with a single peptide CD4+ T lymphocytes develop,19-23 demonstrating that possible differences in the repertoire of peptides presented by positively and negatively selecting cell types alone cannot fully explain the positive/negative selection paradox. An alternative hypothesis on the mechanism of thymic positive/negative selection states that the intensity of TCR triggering determines the selection outcome. A high avidity interaction would lead to negative selection, a very weak signaling to death by neglect, whereas an intermediate TCR-MHC/peptide avidity would allow for positive selection. In fetal thymus organ cultures, it has been shown that the low level expression of agonist MHC/peptide ligand allows the survival of developing thymocytes, supporting the avidity model.24,25 However, when tested, the surviving mature T cells could not be activated by using the same ligand, suggesting that even low avidity interactions do not allow for functional positive selection.26,27 Recent data on the capacity of modified peptide ligands to differentially induce certain, but not other effector functions, suggested that these ligands may also play a role in positive selection (reviewed by Jameson et al28 and Germain and Stefanova29). Studies on TCR-transgenic fetal thymus organ cultures supplemented with modified peptides have suggested a role for these peptides in positive selection.30 However, the fact that altered peptide ligands can also inhibit positive selection,31 and an unexpected MHC/modified peptide ligand-induced mismatch between MHC class specificity and CD4/CD8 lineage outcome32 has complicated the interpretation of altered peptide studies. Finally, a differentiation-state dependent "interpretation" of TCR-mediated signals has been proposed to play a role in positive/negative selection.33,34 In an alternative approach to the paradox of positive/negative selection, we and others have initiated a dissection of the 2 selection processes.8,35-38 We have previously generated irradiation bone marrow chimeras in which radioresistant cells (which are required for positive selection) express MHC molecules, but APCs of hematopoietic origin do not. Although a 2- to 3-fold increase in the rate of development of mature thymocytes was observed, syngeneic reactivity of chimera-derived T cells was rather limited, implying that a significant level of negative selection was still operating in the absence of MHC expression on APCs. Here we report data on transgenic mice expressing MHC class I ligands exclusively on thymic cortical epithelial cells. Although positive selection seems to occur normally in these transgenic mice, no evidence for any negative selection could be observed using in vitro and in vivo assays. Therefore, positive and negative selection seem to be mediated by different cell types expressing self-MHC/peptide ligands.     Materials and methods Top Abstract Introduction Materials and methods Results Discussion References Mice C57BL/6 and DBA/2 mice were obtained from Harlan Netherlands (Zeist, The Netherlands), whereas H-2Kb mutant B6.C-H2bm1- and 2-microglobulin (2m)-deficient C57BL/6-2m° mice39 were purchased from Jackson Laboratories (Bar Harbor, ME). The construct used to generate K14-2m transgenic mice was made as follows: A 0.6-kilobase (kb) SalI/NsiI 2m complementary DNA (cDNA) fragment (generously provided by Dr D. Margulies, National Institutes of Health, Bethesda, MD) was inserted into the BamHI site of pG3Z.K14 (generously provided by Dr E. Fuchs, Howard Hughes Medical Institute, University of Chicago, IL), a vector containing the human keratin 14 (K14) promoter, globin intron, and the K14 poly A addition signal.40 The 3.6-kb transgene was excised with KpnI and HindIII and microinjected into (B6 2m° x C57BL/6)F1 zygotes. Transgenic founders were backcrossed to C57BL/6-2m° mice to obtain K14-2m transgenic, endogenous 2m-deficient mice. Immunohistology Thymi were snap frozen in liquid nitrogen and subsequently placed in OCT (Miles, Elkhard, IN). Cryostat sections (5 µm) were air-dried on frosted microscope slides for at least 2 hours, placed in acetone at room temperature (RT) for 5 minutes, and rehydrated in phosphate-buffered saline (PBS). Blocking was performed for 15 minutes with antibody diluent (Dako, Glostrup, Denmark). Sections were then incubated with monoclonal antibody 6C3 (Pharmingen, San Diego, CA) at a saturating concentration for 30 minutes. After washing with PBS/0.01% Tween20 for 30 minutes, slides were incubated with FITC-labeled antirat IgG F(ab')2 antibody fragment (Immunotech, Marseille, France) for 30 minutes and subsequently washed for 30 minutes. After blocking with mouse Ig (Pierce, Rockford, IL), slides were incubated with biotinylated H-2Kb and H-2Db specific antibody 28-8-6 (Pharmingen), washed, and finally incubated with rhodamine-conjugated streptavidine (Immunotech). After extensive washing, slides were mounted in Faramount (Dako) and analyzed by immunofluorescence microscopy. Flow cytometric analysis Single cell suspensions were prepared from thymus, spleen, and pooled mesenteric, brachial, inguinal, and axillary lymph nodes isolated from K14-2m mice and 2m+/° littermates, as well as from bone marrow from hematopoietic chimeras. Cells were preincubated with 2.4G2 culture supernatant to block Fc receptors,41 washed, and subsequently incubated with antibody for 30 minutes in PBS/2% fetal calf serum (FCS). The following antibodies were used: PE-conjugated anti-CD62L and anti-B220 (Caltag, Burlingame, CA); FITC-conjugated anti-TCR and anti-H-2Kb, PE-conjugated anti-CD4, anti-CD44, anti-CD69, anti-Mac1, and anti-CD11c, and Cy-chrome-labeled anti-CD8 (all from Pharmingen). After 2 washes in PBS/2% FCS, cells were analyzed with a FACScan flow cytometer (Becton Dickinson, San Jose, CA). Cytotoxic T lymphocyte assays Unseparated splenocytes derived from K14-2m transgenic or control (C57BL/6, B6.C-H2bm1 or DBA/2) mice were cultured for 6 days in the presence of T-cell-depleted (anti-Thy1 antibody AT8342 plus complement) irradiated (1000 Rad ) splenocytes in the presence of 30 U/mL IL-2 (EL4 supernatant43). For lysis of RMA and EL-4 targets (C57BL/6 origin43,44), C57BL/6 APC-stimulated effector cells were used, whereas P815 (DBA/2 origin45) lysis assays were performed by using T cells stimulated with DBA/2 APCs. Targets (2000 cells per well) were labeled with 51Cr, extensively washed, and mixed with effector cells in duplicate at effector (viable cell)-to-target (E/T) ratios indicated. 51Cr release in the supernatant was measured 4 hours later. Specific lysis is 51Cr release above background as a percentage of maximum (as determined by acid lysis of targets). For antibody-blocking experiments, effectors were preincubated (30 minutes) with the indicated concentrations of anti-CD4 (GK1.546) or anti-CD8 (H3547) antibodies, then mixed with 51Cr-labeled targets (2000 cells per well) at an E/T ratio required for half maximum lysis. Limiting dilution assays Splenocytes from K14-2m and control (C57BL/6 and B6.C-H2bm1) mice were preincubated with 2.4G2 supernatant,41 and subsequently doubly stained with PE-conjugated anti-CD8 and FITC-conjugated anti-TCR antibodies (Pharmingen). CD8+TCR+ cells were then sorted (with a FACStar Plus sorter, Becton Dickinson, San Jose, CA) directly into 96-well plates containing 2.5 × 106 irradiated (1000 Rad ) C57BL/6 splenocytes per well. Cultures were maintained for 2 weeks in 200 µL Dulbecco modified Eagle medium supplemented with 30 U/mL exogenous IL2 (EL4 supernatant). Half (100 µL) of the cultures were used for standard cytotoxic assays, performed with 51Cr-labeled RMA targets. Lysis was considered positive if 51Cr release exceeded mean + 3 SD of spontaneous release (measured in 48 control wells containing targets and APCs). The frequency of RMA lysing precursors was calculated as described.48 Hematopoietic chimeras Irradiation bone marrow chimeras were prepared essentially as described previously.49 Briefly, anti-NK1.1 antibody-treated hosts (100 µg PK136 intraperitoneally50) were lethally irradiated (1000 Rad ) using a 137Cs source and intravenously reconstituted with 107 C57BL/6 plus C57BL/6-2m° bone marrow cells (ratio 1:1) that had previously been depleted of T cells using anti-Thy1 antibody AT8342 plus complement. Unseparated lymph node cells (107) from transgenic or control mice were coinjected. In some experiments, transgenic lymph node cells were depleted of CD4+ and/or CD8+ T cells before transfer by using anti-CD4 antibody RL172.451 or anti-CD8 antibody 3.16852 plus complement. Chimeras were kept on antibiotic-containing drinking water (0.2% Bactrim, Roche, Basel, Switzerland) for the duration of the experiment (2 weeks).     Results Top Abstract Introduction Materials and methods Results Discussion References Major histocompatibility complex class I expression in K14-2m transgenic mice We have generated transgenic mice that express murine 2m under the control of the human keratin K14 promoter known to be exclusively active in the basal layer of stratified squamous epithelia.40,53 Transgenic mice were crossed to C57BL/6 2m-deficient animals39 and K14-2m transgenic, endogenous 2m-deficient mice identified (K14-2m). Flow cytometric analysis of K14-2m T cells, B cells, macrophages, and dendritic cells from bone marrow, spleen, liver, and thymus demonstrated that these cells do not express detectable levels of MHC class I molecules (Figure 1A; data not shown). In contrast, cortical (but not medullary) epithelial cells in K14-2m transgenic thymi express MHC class I molecules at levels approaching those observed in wild-type controls (Figure 1B). View larger version (52K): [in this window] [in a new window]   Figure 1. MHC class I expression in K14-2m mice. (A) Lack of H-2Kb expression on K14-2m splenic B cells, T cells, macrophages, and dendritic cells. Splenocytes from K14-2m mice (black lines) and 2m+/° littermates (gray lines) were stained with anti-H-2Kb combined with anti-B220, anti-TCR, anti-Mac-1, or anti-CD11c antibodies. Histograms of H-2Kb expression on electronically gated B220+ (B cells), TCR+ (T cells), Mac-1+ (macrophages), or CD11c+ (dendritic cells) subsets are representative of 3 independent experiments. (B) Thymic cortical epithelial expression of MHC class I in K14-2m mice. Sections of wild-type C57BL/6, C57BL/6-2m°, and K14-2m thymi were doubly stained with FITC-conjugated antibody 6C3, which detects cortical epithelial cells, and rhodamine-labeled H-2Kb- and H-2Db-specific antibody 28-8-6. Green and red fluorescence of the same fields is shown. Thymic cortical epithelial expression of major histocompatibility complex class I allows development of CD8+ T lymphocytes We next analyzed the development of mature CD8+ T lymphocytes in K14-2m transgenic mice. Compared with wild-type controls, thymi from transgenic mice contained a 2- to 3-fold increased percentage and an absolute number of mature CD4CD8+TCRhigh thymocytes (Figure 2A). In K14-2m lymph nodes and spleens, normal numbers of CD8+ T lymphocytes were detected (Figure 2A). Moreover, on the basis of the expression of the activation/memory markers CD44, CD62L, and CD69, most CD8+ splenocytes from transgenic as well as wild-type littermates had a naive phenotype (Figure 2B). This result is surprising in view of recent reports indicating that peripheral naive CD8+ T lymphocytes require TCR interactions with MHC class I for their survival.54,55 View larger version (31K): [in this window] [in a new window]   Figure 2. Development and peripheral maintenance of CD8+ T lymphocytes in K14-2m mice. (A) Thymocytes from K14-2m mice and 2m+/° littermates were triply stained with anti-CD4, anti-CD8, and anti-TCR antibodies. Percentages (mean ± SD, n = 6) of CD4CD8, CD4+CD8+, CD4+CD8TCRhigh and CD4CD8+TCRhigh cells are indicated. Thymi from K14-2m mice and 2m+/° littermates contained 127 ± 45 × 106 and 116 ± 25 × 106 cells, respectively. Spleen and lymph node cell suspensions were stained with anti-CD8 and anti-TCR antibodies (n = 3). K14-2m mice and 2m+/° littermates had 98 ± 26 × 106 and 107 ± 25 × 106 splenocytes and 20 ± 6 × 106 and 28 ± 2 × 106 lymph node cells, respectively. (B) Expression of memory/activation markers by CD8+ splenocytes from K14-2m mice and 2m+/° littermates. Cells were stained with anti-TCR, anti-CD8, and anti-CD44, anti-CD62L or anti-CD69 antibodies. Representative histograms of electronically gated TCR+CD8+ cells are shown. Activated CD8+ T lymphocytes from K14-2m mice efficiently lyse syngeneic major histocompatibility complex class I expressing targets in vitro To analyze whether T lymphocytes derived from K14-2m transgenic mice had undergone negative selection, splenocytes were cultured with irradiated syngeneic MHC class I and II expressing (C57BL/6) APCs for 6 days in the presence of exogenous IL-2, followed by an in vitro lysis assay that used C57BL/6-derived RMA or EL-4 lymphomas as targets. K14-2m-derived effector T cells lysed syngeneic targets as efficiently as (allogeneic) B6.C-H2bm1- or DBA/2-derived T cells (Figure 3A). Similar results were obtained with T lymphocytes derived from a second independent K14-2m transgenic mouse line (data not shown). Lysis by both K14-2m- and B6.C-H2bm1-derived effector T cells was completely CD8-dependent, as shown by anti-CD8 antibody blocking (Figure 3B). View larger version (37K): [in this window] [in a new window]   Figure 3. Activated CD8+ T lymphocytes from K14-2m mice lyse MHC class I+ syngeneic targets in vitro. (A) Splenocytes from DBA/2, C57BL/6, B6.C-H2bm1 and K14-2m mice were stimulated in vitro with irradiated C57BL/6 spleen cells in the presence of exogenous IL-2. After 6 days of culture, effector cells were assayed for cytolytic activity using C57BL/6-derived RMA lymphoma target cells at E/T ratios indicated. Data are representative of 3 independent experiments. Similar results were obtained by using C57BL/6-derived EL-4 thymoma cells as targets (data not shown). (B) In vitro-stimulated effector cells from K14-2m and B6.C-H2bm1 mice were incubated for 30 minutes with titrated concentrations of anti-CD4 or anti-CD8 antibodies before addition of labeled RMA target cells. Data are depicted as percentage of lysis in the absence of antibody. (C) Precursor frequency analysis of syngeneic target lysing CD8+ T lymphocytes. Indicated numbers of CD8+TCR+ splenocytes were electronically sorted into 96-well plates seeded with C57BL/6 APCs. Lysis of RMA targets was assessed 2 weeks later. We next analyzed the frequency of autospecific CD8+ K14-2m transgenic T lymphocytes by limiting dilution analysis. The minimal estimate of the H-2b reactive cytotoxic T lymphocyte (CTL) precursor frequency among K14-2m-derived CD8 T lymphocytes was 1 of 48, ie, 7-fold higher than that observed among allogeneic B6.C-H2bm1 CTL (1 of 320), and almost 100-fold higher than that of syngeneic wild-type C57BL/6 cells (1 of 3372) (Figure 3C). These data confirm the high level of autoreactivity of K14-2m-derived CTL. CD8+ T cells from K14-2m mice kill syngeneic major histocompatibility complex class I-expressing hematopoietic targets in vivo T lymphocytes that can be activated by syngeneic MHC ligands in vitro are not necessarily reactive to syngeneic cells in vivo.38,56-58 To assess whether K14-2m-derived T cells were capable of lysing syngeneic targets in vivo, we cotransferred C57BL/6 and C57BL/6-2m° bone marrow as well as K14-2m or control C57BL/6 lymph node T cells into lethally irradiated C57BL/6 hosts. Survival of coinjected C57BL/6 and 2m° bone marrow cells was analyzed by flow cytometry 2 weeks after transfer. In K14-2m T-cell-injected hosts, no MHC class I positive bone marrow precursor cells had survived, and only 2m° bone marrow had reconstituted the hosts (Figure 4A). Moreover, antibody-depletion experiments demonstrated that CD8+ T cells from the K14-2m lymph node cell inoculum were capable of in vivo C57BL/6 bone marrow lysis (Figure 4B). Therefore, CD8+ T lymphocytes developing in K14-2m transgenic mice are capable of lysing targets that express syngeneic MHC class I ligands in vivo as well as in vitro. View larger version (38K): [in this window] [in a new window]   Figure 4. CD8+ T lymphocytes from K14-2m mice kill syngeneic MHC class I+ hematopoietic cells in vivo. Lethally irradiated C57BL/6 hosts were reconstituted with a mixture of C57BL/6 and C57BL/6-2m° bone marrow cells that were cotransferred with C57BL/6 or K14-2m lymph node (LN) cells. Where indicated, the K14-2m lymph node cells were depleted of either CD4+ (LN CD4) or CD4+ plus CD8+ (LN CD4CD8) cells (by antibody plus complement treatment) before transfer. Reconstitution by C57BL/6 bone marrow cells was assessed 2 weeks later by 2-color flow cytometry of bone marrow with the use of anti-CD43 (detecting B cell precursors) and anti-H-2Kb antibodies.     Discussion Top Abstract Introduction Materials and methods Results Discussion References Analysis of the mechanisms responsible for thymic positive and negative selection would be greatly facilitated by the dissection of these processes. Here we have reported data on mice expressing MHC class I molecules under control of the human K14 promoter. In the thymus, MHC class I expression was limited to cortical epithelial cells, and no expression by medullary epithelial cells, T or B lymphocytes, dendritic cells, and macrophages was observed. CD8+ T lymphocytes developed apparently normally and populated peripheral lymphoid organs. These cells could be stimulated to lyse syngeneic targets in vitro as well as in vivo. Therefore, dissection of the thymic positive and negative selection mechanisms can be achieved by using transgenic mice that express MHC class I molecules exclusively on cortical epithelial cells. Expression of transgenic 2m under control of the human K14 promoter in the thymus was limited to cortical epithelial cells, consistent with the results obtained by Laufer and colleagues8 who used transgenic mice that expressed the I-A chain under control of the same promoter construct. In transgenic mice expressing the costimulatory molecule B7-1 under control of a human K14 promoter construct, the expression pattern seemed very different: Medullary (but not cortical) epithelial cells expressed the transgene.59 However, the promoter construct was not identical to the one used by us and by Laufer and colleagues.8,60 Finally, analysis of murine K14 expression in the thymus revealed its exclusive localization in medullary regions.61 Taken together, these data suggest that cortical targeting achieved by us and by Laufer and colleagues critically depends on the promoter construct and is not an inherent characteristic of K14 expression. Thymic cortical epithelial expression of MHC class I molecules in our transgenic mice allowed for efficient positive selection of mature CD8+ thymocytes. Similarly, MHC class II expression by thymic cortical epithelial cells leads to positive selection of mature CD4+ thymocytes.6,8 In contrast, in mice in which MHC class II expression was limited to thymic medullary epithelium, no positive selection of CD4+ T lymphocytes occurred.6 Moreover, MHC class I expression by APCs leads to positive selection of only a minute population of cytotoxic T cells, whereas MHC class II expression by APCs does not allow detectable positive selection of CD4+ T cells.7,9,10,37 It therefore appears that only thymic cortical epithelium supports positive selection of significant numbers of both CD4+6,8 and CD8+ T lymphocytes (our results). In our K14-2m mice, thymic cortical epithelial expression of MHC class I led to the development of 2- to 3-fold increased numbers of mature CD8+ thymocytes. In the absence of MHC class I expression by professional APCs (and therefore of an important fraction of thymic clonal deletion), this increase in mature CD8+ thymocytes was to be expected. Indeed, we have previously shown that in bone marrow chimeras expressing MHC by radioresistant thymic epithelial cells, but lacking MHC expression by APCs, a 2- to 3-fold increase in the rate of generation of mature CD8+ thymocytes occurs.37 Because peripheral naive CD8+ T lymphocytes are believed to require TCR interactions with MHC class I for their survival,54,55 the persistence of normal numbers of peripheral K14-2m CD8+ T cells in the absence of MHC class I expression by professional APCs was rather unexpected. In contrast to naive T cells, memory CD8+ T cells are thought to survive in the absence of continuous TCR-MHC class I interactions,55 though alternative views exist.54 Nevertheless, flow cytometric analysis of K14-2m peripheral CD8+ T cells revealed that the vast majority expressed a naive resting phenotype. Therefore, it appears that even in the absence of MHC class I expression by professional APCs,62 a quantitatively normal CD8+ T-cell repertoire is maintained. The peripheral CD8+ T lymphocyte pool in K14-2m transgenic mice may be maintained by increased thymic egress of mature cells, or alternatively may persist because of TCR interactions with MHC class I expressed extrathymically on epithelial cells.40,53 Additional experiments will be required to distinguish between these 2 possibilities. A significant proportion of peripheral CD8+ T lymphocytes from K14-2m transgenic mice were autospecific and could be induced to lyse syngeneic MHC-expressing target cells in vitro. In bone marrow chimeras lacking MHC class I (J.V.M.V.M. and H.R.M.D., unpublished data, 1997) or MHC class I and II expression38 by hematopoietic cells, but expressing MHC on radioresistant elements (eg, thymic cortical and medullary epithelium), T lymphocytes lysing host-type MHC-expressing target cells in vitro could readily be generated as well. Syngeneic H-2b targets were approximately 10-fold less efficiently lysed by chimera-derived CD8+ T lymphocytes than by allogeneic DBA/2 T cells (our unpublished results, 1997, and van Meerwijk and MacDonald38). In contrast, K14-2m and allogeneic DBA/2 or B6.C-H2bm1 CTL lysed H-2b targets equally efficiently. Moreover, although K14-2m transgenic CTL lysed H-2b targets in vitro as well as in vivo, in the case of PF1 and MHC°wild-type chimeras, as well as in transgenic mice expressing tolerizing ligands exclusively on medullary epithelium, in vitro T-cell reactivity to host or transgene-type MHC was accompanied by in vivo tolerance, a phenomenon termed "split tolerance."38,56-58 Taken together, these data confirm a role for medullary epithelium in negative selection.16,17,58,63,64 Moreover, because mature CD4+ T lymphocytes that had artificially developed in the absence of any MHC-TCR interaction (and therefore MHC-dependent positive or negative selection) were equally reactive to H-2b and H-2d APCs,65 the fact that H-2b targets are lysed equally efficiently by K14-2m as by allogeneic B6.C-H2bm1- and DBA/2-derived T cells strongly suggest that cortical epithelium does not support negative selection. Our data indicating that cortical epithelial cells are incapable of CD8+ T lymphocyte tolerance induction are apparently contradictory to earlier reports showing that in mice expressing transgenic MHC class I restricted TCRs autospecific (cortical) CD4+CD8+ thymocytes were absent (reviewed by Stockinger66). However, deletion observed in these mice is not necessarily due to MHC expressed by cortical epithelial cells and may be mediated by cortical macrophages, a hypothesis consistent with the relatively poor TCR-transgenic CD4+CD8+ thymocyte deletion by ligand-expressing thymic epithelial cells.67 Data suggesting that other mechanisms may be involved in the depletion of autospecific TCR transgenic CD4+CD8+ thymocytes have also been reported.68,69 The frequency of autoreactive CTL precursors in K14-2m mice (as determined by limiting dilution analysis) was 1 of 48, a value similar to that obtained by Laufer and colleagues for autoreactive CD4+ T-cell precursors.8 These data suggest that only 2% of positively selectable thymocytes normally undergo tolerance induction, a value well below the 50% to 70% obtained earlier by us and by others analyzing T-hybrid specificity and kinetics of mature CD4+ or CD8+ thymocyte development.22,37,65 However, values obtained by limiting dilution analysis are necessarily minimal estimates, and (in the absence of a valid correction for plating efficiency) cannot be compared with kinetic and T-hybrid data. In conclusion, our data indicate that MHC class I expressed by cortical epithelial cells cannot induce negative selection of CD8+ T lymphocytes, a conclusion consistent with earlier data on reactivity of CD4+ T cells that had developed in mice expressing MHC class II exclusively on cortical epithelium.8,35 Therefore, cortical epithelial cells appear to be specialized in thymic positive selection, whereas medullary epithelial cells and intrathymic APCs of hematopoietic origin are specialized in negative selection. Although certain in vitro cultured thymic epithelial cell lines are capable of both positive and negative selection in vitro and when injected intrathymically,70,71 the physiologic relevance of these findings remains unclear. Whatever the explanation, the data presented here and elsewhere8,35 on K14-MHC transgenic mice clearly point to a general lack of tolerance induction by cortical epithelial cells. The ability to dissect thymic positive and negative selection by using these mice should facilitate analysis of the responsible mechanisms.     Acknowledgments We thank Dr E. Fuchs for the K14 promoter construct, Dr D. Margulies for 2m cDNA, Dr C. L. Blanchard for constructing the K14-2m vector, Dr M. Guttinger for helpful suggestions, and R. Lees and G. Enault for expert technical help.     Footnotes Submitted September 18, 2000; accepted October 9, 2000. Supported in part by grants from ARC (#7287), Région Midi Pyrénées (RECH/97001940), FRM (10000121-10), and by institutional funds from INSERM and University Toulouse III. The publication costs of this article were defrayed in part by page charge payment. Therefore, and solely to indicate this fact, this article is hereby marked "advertisement" in accordance with 18 U.S.C. section 1734. Reprints: Joost P. M. van Meerwijk, INSERM U395 CHU Purpan, BP 3028, 31024 Toulouse Cedex 3, France; e-mail: joost.van-meerwijk{at}purpan.inserm.fr.     References Top Abstract Introduction Materials and methods Results Discussion References 1. Anderson G, Moore NC, Owen JJT, Jenkinson EJ. Cellular interactions in thymocyte development. Annu Rev Immunol. 1996;14:73-99[CrossRef][Medline] [Order article via Infotrieve]. 2. Guidos CJ. Positive selection of CD4+ and CD8+ T cells. Curr Opin Immunol. 1996;8:225-232[CrossRef][Medline] [Order article via Infotrieve]. 3. Sebzda E, Mariathasan S, Ohteki T, et al. Selection of the T cell repertoire. Annu Rev Immunol. 1999;17:829-874[CrossRef][Medline] [Order article via Infotrieve]. 4. Anderson G, Hare KJ, Jenkinson EJ. Positive selection of thymocytes: the long and winding road. Immunol Today. 1999;20:463-468[CrossRef][Medline] [Order article via Infotrieve]. 5. Matzinger P. Why positive selection? Immunol Rev. 1993;135:81-117[CrossRef][Medline] [Order article via Infotrieve]. 6. Cosgrove D, Chan SH, Waltzinger C, Benoist C, Mathis D. The thymic compartment responsible for positive selection of CD4+ T cells. Int Immunol. 1992;4:707-710[Abstract/Free Full Text]. 7. Markowitz JS, Auchincloss HJ, Grusby MJ, Glimcher LH. Class II-positive hematopoietic cells cannot mediate positive selection of CD4+ T lymphocytes in class II-deficient mice. Proc Natl Acad Sci U S A. 1993;90:2779-2783[Abstract/Free Full Text]. 8. Laufer TM, DeKoning J, Markowitz JS, Lo D, Glimcher LH. Unopposed positive selection and autoreactivity in mice expressing class II MHC only on thymic cortex. Nature. 1996;383:81-85[CrossRef][Medline] [Order article via Infotrieve]. 9. Bix M, Raulet D. Inefficient positive selection of T cells directed by haematopoietic cells. Nature. 1992;359:330-333[CrossRef][Medline] [Order article via Infotrieve]. 10. Zerrahn J, Volkmann A, Coles MC, et al. Class I MHC molecules on hematopoietic cells can support intrathymic positive selection of T cell receptor transgenic T cells. Proc Natl Acad Sci U S A. 1999;96:11470-11475[Abstract/Free Full Text]. 11. Laufer TM, Glimcher LH, Lo D. Using thymus anatomy to dissect T cell repertoire selection. Semin Immunol. 1999;11:65-70[CrossRef][Medline] [Order article via Infotrieve]. 12. Marrack P, Ignatowicz L, Kappler JW, Boymel J, Freed JH. Comparison of peptides bound to spleen and thymus class II. J Exp Med. 1993;178:2173-2183[Abstract/Free Full Text]. 13. Oukka M, Andre P, Turmel P, et al. Selectivity of the major histocompatibility complex class II presentation pathway of cortical thymic epithelial cell lines. Eur J Immunol. 1997;27:855-859[Medline] [Order article via Infotrieve]. 14. Kasai M, Hirokawa K, Kajino K, et al. Difference in antigen presentation pathways between cortical and medullary thymic epithelial cells. Eur J Immunol. 1996;26:2101-2107[Medline] [Order article via Infotrieve]. 15. Marrack P, McCormack J, Kappler J. Presentation of antigen, foreign major histocompatibility complex proteins and self by thymus cortical epithelium. Nature. 1989;338:503-505[CrossRef][Medline] [Order article via Infotrieve]. 16. Oukka M, Cohen-Tannoudji M, Tanaka Y, Babinet C, Kosmatopoulos K. Medullary thymic epithelial cells induce tolerance to intracellular proteins. J Immunol. 1996;156:968-975[Abstract]. 17. Klein L, Klein T, Ruther U, Kyewski B. CD4 T cell tolerance to human C-reactive protein, an inducible serum protein, is mediated by medullary thymic epithelium. J Exp Med. 1998;188:5-16[Abstract/Free Full Text]. 18. Nakagawa T, Roth W, Wong P, et al. Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science. 1998;280:450-453[Abstract/Free Full Text]. 19. Miyazaki T, Wolf P, Tourne S, et al. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell. 1996;84:531-541[CrossRef][Medline] [Order article via Infotrieve]. 20. Martin WD, Hicks GG, Mendiratta SK, et al. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 1996;84:543-550[CrossRef][Medline] [Order article via Infotrieve]. 21. Liu CP, Parker D, Kappler J, Marrack P. Selection of antigen-specific T cells by a single IEk peptide combination. J Exp Med. 1997;186:1441-1450[Abstract/Free Full Text]. 22. Ignatowicz L, Kappler J, Marrack P. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell. 1996;84:521-529[CrossRef][Medline] [Order article via Infotrieve]. 23. Fung-Leung W-P, Surh CD, Liljedahl M, et al. Antigen presentation and T cell development in H2-M-deficient mice. Science. 1996;271:1278-1281[Abstract]. 24. Ashton-Rickardt PG, Bandeira A, Delaney JR, et al. Evidence for a differential avidity model of T cell selection in the thymus. Cell. 1994;76:651-663[CrossRef][Medline] [Order article via Infotrieve]. 25. Sebzda E, Wallace VA, Mayer J, et al. Positive and negative thymocyte selection induced by different concentrations of a single peptide. Science. 1994;263:1615-1618[Abstract/Free Full Text]. 26. Sebzda E, Kuendig TM, Thomson CT, et al. Mature T cell reactivity altered by peptide agonist that induces positive selection. J Exp Med. 1996;183:1093-1104[Abstract/Free Full Text]. 27. Hogquist KA, Jameson SC, Bevan MJ. Strong agonist ligands for the T cell receptor do not mediate positive selection of functional CD8+ T cells. Immunity. 1995;3:79-86[CrossRef][Medline] [Order article via Infotrieve]. 28. Jameson SC, Hogquist KA, Bevan MJ. Positive selection of thymocytes. Annu Rev Immunol. 1995;13:93-126[CrossRef][Medline] [Order article via Infotrieve]. 29. Germain RN, Stefanova I. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu Rev Immunol. 1999;17:467-522[CrossRef][Medline] [Order article via Infotrieve]. 30. Sloan-Lancaster J, Allen PM. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu Rev Immunol. 1996;14:1-27[CrossRef][Medline] [Order article via Infotrieve]. 31. Spain LM, Jorgensen JL, Davis MM, Berg LJ. A peptide antigen antagonist prevents the differentiation of T cell receptor transgenic thymocytes. J Immunol. 1994;152:1709-1717[Abstract]. 32. Volkmann A, Barthlott T, Weiss S, Frank R, Stockinger B. Antagonist peptide selects thymocytes expressing a class II major histocompatibility complex-restricted T cell receptor into the CD8 lineage. J Exp Med. 1998;188:1083-1089[Abstract/Free Full Text]. 33. Lucas B, Stefanova I, Yasutomo K, Dautigny N, Germain RN. Divergent changes in the sensitivity of maturing T cells to structurally related ligands underlies formation of a useful T cell repertoire. Immunity. 1999;10:367-376[CrossRef][Medline] [Order article via Infotrieve]. 34. Davey GM, Schober SL, Endrizzi BT, et al. Preselection thymocytes are more sensitive to T cell receptor stimulation than mature T cells. J Exp Med. 1998;188:1867-1874[Abstract/Free Full Text]. 35. Laufer TM, Fan L, Glimcher LH. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J Immunol. 1999;162:5078-5084[Abstract/Free Full Text]. 36. DeKoning J, DiMolfetto L, Reilly C, et al. Thymic cortical epithelium is sufficient for the development of mature T cells in relB-deficient mice. J Immunol. 1997;158:2558-2566[Abstract]. 37. van Meerwijk JPM, Marguerat S, Lees RK, et al. Quantitative impact of thymic clonal deletion on the T cell repertoire. J Exp Med. 1997;185:377-383[Abstract/Free Full Text]. 38. van Meerwijk JPM, MacDonald HR. In vivo T lymphocyte tolerance in the absence of thymic clonal deletion mediated by haematopoietic cells. Blood. 1999;93:3856-3862[Abstract/Free Full Text]. 39. Zijlstra M, Li E, Sajjadi F, Subramani S, Jaenisch R. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells. Nature. 1989;342:435-438[CrossRef][Medline] [Order article via Infotrieve]. 40. Vassar R, Fuchs E. Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes Dev. 1991;5:714-727[Abstract/Free Full Text]. 41. Unkeless JC. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors. J Exp Med. 1979;150:580-596[Abstract/Free Full Text]. 42. Sarmiento M, Loken MR, Fitch FW. Structural differences in cell surface T25 polypeptides from thymocytes and cloned T cells. Hybridoma. 1981;1:13-26[Medline] [Order article via Infotrieve]. 43. Farrar JJ, Fuller-Farrar J, Simon PL, et al. Thymoma production of T cell growth factor (Interleukin 2). J Immunol. 1980;125:2555-2558[Abstract]. 44. Ljunggren HG, Paabo S, Cochet M, et al. Molecular analysis of H-2-deficient lymphoma lines: distinct defects in biosynthesis and association of MHC class I heavy chains and beta 2- microglobulin observed in cells with increased sensitivity to NK cell lysis. J Immunol. 1989;142:2911-2917[Abstract]. 45. Ralph P, Nakoinz I. Direct toxic effects of immunopotentiators on monocytic, myelomonocytic, and histiocytic or macrophage tumor cells in culture. Cancer Res. 1977;37:546-550[Abstract/Free Full Text]. 46. Dialynas DP, Quan ZS, Wall KA, et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol. 1983;131:2445-2451[Abstract]. 47. Golstein P, Goridis C, Schmitt-Verhulst A-M, et al. Lymphoid cell surface interaction structures detected using cytolysis-inhibiting monoclonal antibodies. Immunol Rev. 1982;68:5-42[CrossRef][Medline] [Order article via Infotrieve]. 48. Taswell C. Limiting dilution assays for the determination of immunocompetent cell frequencies, I: data analysis. J Immunol. 1981;126:1614-1619[Abstract]. 49. van Meerwijk JPM, O'Connell EM, Germain RN. Evidence for lineage commitment and initiation of positive selection by thymocytes with intermediate surface phenotypes. J Immunol. 1995;154:6314-6324[Abstract]. 50. Koo GC, Peppard JR. Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma. 1984;3:301-303[Medline] [Order article via Infotrieve]. 51. Ceredig R, Lowenthal JW, Nabholz M, MacDonald HR. Expression of interleukin-2 receptors as a differentiation marker on intrathymic stem cells. Nature. 1985;314:98-100[CrossRef][Medline] [Order article via Infotrieve]. 52. Sarmiento M, Dialynas DP, Lancki DW, et al. Cloned T lymphocytes and monoclonal antibodies as probes for cell surface molecules active in T cell-mediated cytolysis. Immunol Rev. 1982;68:135-169[CrossRef][Medline] [Order article via Infotrieve]. 53. Vassar R, Rosenberg M, Ross S, Tyner A, Fuchs E. Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proc Natl Acad Sci U S A. 1989;86:1563-1567[Abstract/Free Full Text]. 54. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science. 1997;276:2057-2062[Abstract/Free Full Text]. 55. Murali-Krishna K, Lau LL, Sambhara S, et al. Persistence of memory CD8 T cells in MHC class I-deficient mice. Science. 1999;286:1377-1381[Abstract/Free Full Text]. 56. Sprent J, Kosaka H, Gao E-K, Surh CD, Webb SR. Intrathymic and extrathymic tolerance in bone marrow chimeras. Immunol Rev. 1993;133:151-176[CrossRef][Medline] [Order article via Infotrieve]. 57. Sprent J, Hurd M, Schaefer M, Heath W. Split tolerance in spleen chimeras. J Immunol. 1995;154:1198-1206[Abstract]. 58. Hoffmann MW, Allison J, Miller JF. Tolerance induction by thymic medullary epithelium. Proc Natl Acad Sci U S A. 1992;89:2526-2530[Abstract/Free Full Text]. 59. Burns RP Jr, Nasir A, Haake AR, Barth RK, Gaspari AA. B7-1 overexpression by thymic epithelial cells results in transient and long-lasting effects on thymocytes and peripheral T helper cells but does not result in immunodeficiency. Cell Immunol. 1999;194:162-177[CrossRef][Medline] [Order article via Infotrieve]. 60. Nasir A, Ferbel B, Salminen W, Barth RK, Gaspari AA. Exaggerated and persistent cutaneous delayed-type hypersensitivity in transgenic mice whose epidermal keratinocytes constitutively express B7-1 antigen. J Clin Invest. 1994;94:892-898. 61. Klug DB, Carter C, Crouch E, et al. Interdependence of cortical thymic epithelial cell differentiation and T-lineage commitment. Proc Natl Acad Sci U S A. 1998;95:11822-11827[Abstract/Free Full Text]. 62. Brocker T. Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells. J Exp Med. 1997;186:1223-1232[Abstract/Free Full Text]. 63. Schonrich G, Momburg F, Hammerling GJ, Arnold B. Anergy induced by thymic medullary epithelium. Eur J Immunol. 1992;22:1687-1691[Medline] [Order article via Infotrieve]. 64. Burkly LC, Degermann S, Longley J, et al. Clonal deletion of V beta 5+ T cells by transgenic I-E restricted to thymic medullary epithelium. J Immunol. 1993;151:3954-3960[Abstract]. 65. Zerrahn J, Held W, Raulet DH. The MHC reactivity of the T cell repertoire prior to positive and negative selection. Cell. 1997;88:627-636[CrossRef][Medline] [Order article via Infotrieve]. 66. Stockinger B. T lymphocyte tolerance: from thymic deletion to peripheral control mechanisms. Adv Immunol. 1999;71:229-265[Medline] [Order article via Infotrieve]. 67. Carlow DA, Teh SJ, Teh HS. Altered thymocyte development resulting from expressing a deleting ligand on selecting thymic epithelium. J Immunol. 1992;148:2988-2995[Abstract]. 68. Takahama Y, Shores EW, Singer A. Negative selection of precursor thymocytes before their differentiation into CD4+CD8+ cells. Science. 1992;258:653-656[Abstract/Free Full Text]. 69. Martin S, Bevan MJ. Antigen-specific and nonspecific deletion of immature cortical thymocytes caused by antigen injection. Eur J Immunol. 1997;27:2726-2736[Medline] [Order article via Infotrieve]. 70. Hugo P, Kappler JW, Godfrey DI, Marrack PC. Thymic epithelial cell lines that mediate positive selection can also induce thymocyte clonal deletion. J Immunol. 1994;152:1022-1031[Abstract]. 71. Vukmanovic S, Jameson SC, Bevan MJ. A thymic epithelial cell line induces both positive and negative selection in the thymus. Int Immunol. 1994;6:239-246[Abstract/Free Full Text]. © 2001 by The American Society of Hematology.   CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this? This article has been cited by other articles: G. P. Marcuzzi, M. Hufbauer, H. U. Kasper, S. J. Weissenborn, S. Smola, and H. Pfister Spontaneous tumour development in human papillomavirus type 8 E6 transgenic mice and rapid induction by UV-light exposure and wounding J. Gen. Virol., December 1, 2009; 90(12): 2855 - 2864. [Abstract] [Full Text] [PDF] T. M. McCaughtry, T. A. Baldwin, M. S. Wilken, and K. A. Hogquist Clonal deletion of thymocytes can occur in the cortex with no involvement of the medulla J. Exp. Med., October 27, 2008; 205(11): 2575 - 2584. [Abstract] [Full Text] [PDF] J. Ribot, G. Enault, S. Pilipenko, A. Huchenq, M. Calise, D. Hudrisier, P. Romagnoli, and J. P. M. van Meerwijk Shaping of the Autoreactive Regulatory T Cell Repertoire by Thymic Cortical Positive Selection J. Immunol., November 15, 2007; 179(10): 6741 - 6748. [Abstract] [Full Text] [PDF] P. Romagnoli, D. Hudrisier, and J. P. M. van Meerwijk Molecular Signature of Recent Thymic Selection Events on Effector and Regulatory CD4+ T Lymphocytes J. Immunol., November 1, 2005; 175(9): 5751 - 5758. [Abstract] [Full Text] [PDF] A. Gruber and T. Brocker MHC Class I-Positive Dendritic Cells (DC) Control CD8 T Cell Homeostasis In Vivo: T Cell Lymphopenia as a Prerequisite for DC-Mediated Homeostatic Proliferation of Naive CD8 T Cells J. Immunol., July 1, 2005; 175(1): 201 - 206. [Abstract] [Full Text] [PDF] D. Daniel, C. Chiu, E. Giraudo, M. Inoue, L. A. Mizzen, N. R. Chu, and D. Hanahan CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer Cancer Res., March 1, 2005; 65(5): 2018 - 2025. [Abstract] [Full Text] [PDF] A. M. Gallegos and M. J. Bevan Central Tolerance to Tissue-specific Antigens Mediated by Direct and Indirect Antigen Presentation J. Exp. Med., October 18, 2004; 200(8): 1039 - 1049. [Abstract] [Full Text] [PDF] M. A. Cannarile, N. Decanis, J. P. M. van Meerwijk, and T. Brocker The Role of Dendritic Cells in Selection of Classical and Nonclassical CD8+ T Cells In Vivo J. Immunol., October 15, 2004; 173(8): 4799 - 4805. [Abstract] [Full Text] [PDF] E. Esashi, H. Ito, K. Ishihara, T. Hirano, S. Koyasu, and A. Miyajima Development of CD4+ Macrophages from Intrathymic T Cell Progenitors Is Induced by Thymic Epithelial Cells J. Immunol., October 1, 2004; 173(7): 4360 - 4367. [Abstract] [Full Text] [PDF] O. Joffre, N. Gorsse, P. Romagnoli, D. Hudrisier, and J. P. M. van Meerwijk Induction of antigen-specific tolerance to bone marrow allografts with CD4+CD25+ T lymphocytes Blood, June 1, 2004; 103(11): 4216 - 4221. [Abstract] [Full Text] [PDF] J. Faro, S. Velasco, A. Gonzalez-Fernandez, and A. Bandeira The Impact of Thymic Antigen Diversity on the Size of the Selected T Cell Repertoire J. Immunol., February 15, 2004; 172(4): 2247 - 2255. [Abstract] [Full Text] [PDF] D. Mayerova and K. A. Hogquist Central Tolerance to Self-Antigen Expressed by Cortical Epithelial Cells J. Immunol., January 15, 2004; 172(2): 851 - 856. [Abstract] [Full Text] [PDF] S. R. Permar, W. J. Moss, J. J. Ryon, D. C. Douek, M. Monze, and D. E. Griffin Increased Thymic Output during Acute Measles Virus Infection J. Virol., July 15, 2003; 77(14): 7872 - 7879. [Abstract] [Full Text] [PDF] T. Teshima, P. Reddy, C. Liu, D. Williams, K. R. Cooke, and J. L. M. Ferrara Impaired thymic negative selection causes autoimmune graft-versus-host disease Blood, July 15, 2003; 102(2): 429 - 435. [Abstract] [Full Text] [PDF] R. Terra, N. Labrecque, and C. Perreault Thymic and Extrathymic T Cell Development Pathways Follow Different Rules J. Immunol., July 15, 2002; 169(2): 684 - 692. [Abstract] [Full Text] [PDF] P. Romagnoli, D. Hudrisier, and J. P. M. van Meerwijk Preferential Recognition of Self Antigens Despite Normal Thymic Deletion of CD4+CD25+ Regulatory T Cells J. Immunol., February 15, 2002; 168(4): 1644 - 1648. [Abstract] [Full Text] [PDF] H. E. Stefanski, D. Mayerova, S. C. Jameson, and K. A. Hogquist A Low Affinity TCR Ligand Restores Positive Selection of CD8+ T Cells In Vivo J. Immunol., June 1, 2001; 166(11): 6602 - 6607. [Abstract] [Full Text] [PDF] This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Rights and Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Capone, M. Articles by van Meerwijk, J. P. M. Search for Related Content PubMed PubMed Citation Articles by Capone, M. Articles by van Meerwijk, J. P. M. Related Collections Immunobiology Social Bookmarking                   What's this?

	Copyright © 2001 by American Society of Hematology         Online ISSN: 1528-0020